skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 416  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: Coronavirus Research Database remove Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
2019-nCoV transmission through the ocular surface must not be ignored
Material Type:
Article
Add to My Research

2019-nCoV transmission through the ocular surface must not be ignored

The Lancet, 2020-02, Vol.395 (10224), p.e39-e39 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30313-5 ;PMID: 32035510

Digital Resources/Online E-Resources

2
Comorbidities and multi-organ injuries in the treatment of COVID-19
Material Type:
Article
Add to My Research

Comorbidities and multi-organ injuries in the treatment of COVID-19

The Lancet, 2020-03, Vol.395 (10228), p.e52-e52 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30558-4 ;PMID: 32171074

Digital Resources/Online E-Resources

3
Retinal findings in patients with COVID-19
Material Type:
Article
Add to My Research

Retinal findings in patients with COVID-19

The Lancet, 2020-05, Vol.395 (10237), p.1610-1610 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31014-X ;PMID: 32405105

Digital Resources/Online E-Resources

4
Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

The Lancet, 2020-06, Vol.395 (10242), p.1973-1987 [Peer Reviewed Journal]

2020 World Health Organization ;2020 World Health Organization. Published by Elsevier Ltd. This is an Open Access article published under the CC BY 3.0 IGO license which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any use of this article, there should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 World Health Organization 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31142-9 ;PMID: 32497510

Digital Resources/Online E-Resources

5
How to fight an infodemic
Material Type:
Article
Add to My Research

How to fight an infodemic

The Lancet, 2020-02, Vol.395 (10225), p.676-676 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30461-X ;PMID: 32113495

Digital Resources/Online E-Resources

6
COVID-19: protecting health-care workers
Material Type:
Article
Add to My Research

COVID-19: protecting health-care workers

The Lancet, 2020-03, Vol.395 (10228), p.922-922 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30644-9 ;PMID: 32199474

Digital Resources/Online E-Resources

7
Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?
Material Type:
Article
Add to My Research

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

The Lancet, 2020-04, Vol.395 (10230), p.1111-1111 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30691-7 ;PMID: 32220278

Digital Resources/Online E-Resources

8
Offline: COVID-19 is not a pandemic
Material Type:
Article
Add to My Research

Offline: COVID-19 is not a pandemic

The Lancet, 2020-09, Vol.396 (10255), p.874-874 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32000-6 ;PMID: 32979964

Digital Resources/Online E-Resources

9
COVID-19 in Europe: the Italian lesson
Material Type:
Article
Add to My Research

COVID-19 in Europe: the Italian lesson

The Lancet, 2020-04, Vol.395 (10230), p.1110-1111 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30690-5 ;PMID: 32220279

Digital Resources/Online E-Resources

10
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet, 2020-10, Vol.396 (10259), p.1345-1352 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32013-4 ;PMID: 33031764

Digital Resources/Online E-Resources

11
Parenting in a time of COVID-19
Material Type:
Article
Add to My Research

Parenting in a time of COVID-19

The Lancet, 2020-04, Vol.395 (10231), p.e64-e64 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30736-4 ;PMID: 32220657

Digital Resources/Online E-Resources

12
The COVID-19 syndemic is not global: context matters
Material Type:
Article
Add to My Research

The COVID-19 syndemic is not global: context matters

The Lancet, 2020-11, Vol.396 (10264), p.1731-1731 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32218-2 ;PMID: 33256917

Digital Resources/Online E-Resources

13
A novel coronavirus outbreak of global health concern
Material Type:
Article
Add to My Research

A novel coronavirus outbreak of global health concern

The Lancet, 2020-02, Vol.395 (10223), p.470-473 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30185-9 ;PMID: 31986257

Digital Resources/Online E-Resources

14
Clinical course and mortality risk of severe COVID-19
Material Type:
Article
Add to My Research

Clinical course and mortality risk of severe COVID-19

The Lancet, 2020-03, Vol.395 (10229), p.1014-1015 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30633-4 ;PMID: 32197108

Digital Resources/Online E-Resources

15
Beware of the second wave of COVID-19
Material Type:
Article
Add to My Research

Beware of the second wave of COVID-19

The Lancet, 2020-04, Vol.395 (10233), p.1321-1322 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30845-X ;PMID: 32277876

Digital Resources/Online E-Resources

16
On the use of corticosteroids for 2019-nCoV pneumonia
Material Type:
Article
Add to My Research

On the use of corticosteroids for 2019-nCoV pneumonia

The Lancet, 2020-02, Vol.395 (10225), p.683-684 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30361-5 ;PMID: 32122468

Digital Resources/Online E-Resources

17
Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Material Type:
Article
Add to My Research

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

The Lancet, 2020-05, Vol.395 (10238), p.1695-1704 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31042-4 ;PMID: 32401715

Digital Resources/Online E-Resources

18
Racism and discrimination in COVID-19 responses
Material Type:
Article
Add to My Research

Racism and discrimination in COVID-19 responses

The Lancet, 2020-04, Vol.395 (10231), p.1194-1194 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30792-3 ;PMID: 32246915

Digital Resources/Online E-Resources

19
Electron microscopy of SARS-CoV-2: a challenging task
Material Type:
Article
Add to My Research

Electron microscopy of SARS-CoV-2: a challenging task

The Lancet, 2020-05, Vol.395 (10238), p.e99-e99 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31188-0 ;PMID: 32442529

Digital Resources/Online E-Resources

20
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
Material Type:
Article
Add to My Research

Baricitinib as potential treatment for 2019-nCoV acute respiratory disease

The Lancet, 2020-02, Vol.395 (10223), p.e30-e31 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30304-4 ;PMID: 32032529

Digital Resources/Online E-Resources

Results 1 - 20 of 416  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait